| Type | Indexed | Publication . Mgi Jnum | J:349051 |
| Publication . Citation | Lee JW, et al. (2019) The Combination of MEK Inhibitor With Immunomodulatory Antibodies Targeting Programmed Death 1 and Programmed Death Ligand 1 Results in Prolonged Survival in Kras/p53-Driven Lung Cancer. J Thorac Oncol 14(6):1046-1060 |